Midsize pharma company stabilizes API - Accelerates time to clinic from three months to three weeks

Case study

A midsize pharma company wanted to progress its therapy from early development to late-phase clinical trial stage, but needed a CDMO partner to provide support in formulation analysis so that it could stabilize its product and successfully reach its clinical studies milestones.

Download case study

Ready to discuss your project?

Connect with us